Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils
Despite great achievements in neonatal and perinatal medicine over the past decades, the immature lung remains the most critical organ to care for after premature birth. As a consequence, bronchopulmonary dysplasia (BPD) remains the most common complication of extreme prematurity. BPD impairs normal development and may cause lifelong morbidities. At present, there is no effective treatment for BPD – including preventing premature birth. Recent insights into the biology of stem and progenitor cells have ignited the hope of protecting the immature lung, and even regenerating an already damaged lung by using exogenous stem- or progenitor cells as therapeutics.
Source: Paediatric Respiratory Reviews - Category: Respiratory Medicine Authors: Marius Alexander M öbius, Bernard Thébaud Tags: Today's Science - Tomorrow's Medicine Source Type: research
More News: Biology | Bronchopulmonary Dysplasia | Pediatrics | Perinatology & Neonatology | Premature Birth | Respiratory Medicine | Science